You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 99 No. 9, September 1981 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Digoxin Retinal Toxicity

Clinical and Electrophysiologic Evaluation of a Cone Dysfunction Syndrome

Richard G. Weleber, MD; William T. Shults, MD

Arch Ophthalmol. 1981;99(9):1568-1572.


Abstract

• A 70-year-old man was studied both during and after resolution of clinical digoxin toxicity using color vision tests, ganzfeld electroretinography, and electrooculography. Concomitant administration of quinidine sulfate probably contributed to digoxin toxicity. Abnormalities in color vision and subnormal amplitude and prolonged implicit time for cone-mediated electroretinogram (ERG) responses suggested a cone dysfunction syndrome. The electro-oculographic light-to-dark ratio during clinical toxicity was high for our laboratory, but this is probably normal. Notable improvement was seen in color vision and the ERG after cessation of digoxin therapy. Inhibition of sodium-potassium adenosine triphosphatase by digoxin probably influences normal uptake of extracellular potassium by Müller's cells and other retinal neurons. This mechanism may contribute to subnormal, prolonged cone-mediated ERG responses in retinal toxic reactions from cardiac glycosides.



Author Affiliations

From the Department of Ophthalmology, University of Oregon Health Sciences Center (Drs Weleber and Shults), and the Devers Eye Clinic of Good Samaritan Hospital, Portland, Ore (Dr Shults).


Footnotes

Accepted for publication Nov 19, 1980.

Reprint requests to the Department of Ophthalmology, University of Oregon Health Sciences Center, 3181 SW Sam Jackson Park Rd, Portland, OR 97201 (Dr Weleber).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Acquired colour vision deficiency in patients receiving digoxin maintenance therapy
Lawrenson et al.
Br. J. Ophthalmol. 2002;86:1259-1261.
ABSTRACT | FULL TEXT  

Electrophysiologic and Electroretinographic Evidence for Photoreceptor Dysfunction as a Toxic Effect of Digoxin
Madreperla et al.
Arch Ophthalmol 1994;112:807-812.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.